In The Press

“This startup raised $38 million to fill one of the biggest gaps in drug discovery”

Forbes
•
Nov 22, 2023
Share on

Discover More Articles

view all posts
Vivodyne At The 2024 Forbes Healthcare Summit: The New Era Of Drug Discovery
Modeling Integrated Human Physiology - AWS Health Innovation Podcast (Episode 87)
Vivodyne Appoints Julie O'Shaughnessy as Chief Operating Officer
Vivodyne Appoints Elliot Menschik as Chief Technology Officer
"One founder is using lab-grown human organs in combination with AI to test drug efficacy."
Human data before the clinic.
Connect With Us
Applications
Philadelphia, USA
© 2024 Vivodyne
Privacy
linkedinlinkedinxx